Skip to main content

Day: December 18, 2019

Italeaf: the Board of Directors of the subsidiary TerniEnergia approved the Half-Yearly Financial Report as at 30 June 2019

PRESS RELEASE 18 DECEMBER 2019Italeaf: the Board of Directors of the subsidiary TerniEnergia approved the Half-Yearly Financial Report as at 30 June 2019Reviewed the TerniEnergia Group’s economic and financial performance and the progress of the Recovery and Relaunch Plan: strong recovery of profitability and improvement of operations in the second half of 2019Revenues for the half-year amount to Euro 11 million (Euro 11.2 million as at 30/6/2018)EBITDA equal to Euro 0.3 million (Euro 0.7 million as at 30/6/2018) with Ebitda Margin at 3.1%.EBIT equal to Euro -2.7 million (Euro -1.3 million as at 30/6/2018), Earnings before taxes (EBT) equal to Euro -4.4 million (Euro -3.6 million as at 30/6/2018)Net result of Euro -3.3 million (Euro -3.5 million as at 30/6/2018)Net Financial Position of Euro 66.7 million (Euro 65.2 million at 31/12/2018)Shareholders’...

Continue reading

Italeaf: Il CdA della controllata TerniEnergia approva la Relazione finanziaria semestrale al 30 giugno 2019

COMUNICATO STAMPA 18 DICEMBRE 2019Italeaf: Il CdA della controllata TerniEnergia approva la Relazione finanziaria semestrale al 30 giugno 2019Esaminato l’andamento economico-finanziario del Gruppo TerniEnergia e lo stato di avanzamento del Piano di Risanamento e Rilancio: forte recupero della profittabilità e miglioramento della gestione operativa nella seconda metà del 2019Ricavi del semestre pari a Euro 11 milioni (Euro 11,2 milioni al 30/6/2018)EBITDA pari a Euro 0,3 milioni (Euro 0,7 milioni al 30/6/2018) con Ebitda Margin al 3,1%EBIT pari a Euro -2,7 milioni (Euro -1,3 milioni al 30/6/2018), Risultato ante imposte (EBT) pari a Euro -4,4 milioni (Euro -3,6 milioni al 30/6/2018)Risultato Netto pari a Euro -3,3 milioni (Euro -3,5 milioni al 30/6/2018)Posizione Finanziaria Netta pari a Euro 66,7 milioni (Euro 65,2...

Continue reading

UNISYNC Reports Improved Fourth Quarter Financial Results

VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) — Unisync Corp. (the “Company”)(TSX:”UNI”) generated revenue of $20.4 million for the three months ended September 30, 2019, an increase of $8.6 million or 73% over the three months ended September 30, 2018.The Company operates through two business segments: Unisync Group Limited (“UGL”) with its North American head office in Mississauga, Ontario and Peerless Garments LP based in Winnipeg, Manitoba (“Peerless”). UGL is a leading customer-­focused provider of corporate apparel, serving many leading Canadian and American iconic brands. Peerless specializes in the production and distribution of highly technical protective garments, military operational clothing and accessories for a broad spectrum of Federal, Provincial and...

Continue reading

TELA Bio Announces Third Quarter 2019 Financial Results

Revenue increased 80% year-over-year to $4.0 millionCompleted initial public offering in November 2019, raising net proceeds of $50.7 millionMALVERN, Pa., Dec. 18, 2019 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported financial results for the three months ended September 30, 2019. “Continued strong growth in the third quarter demonstrates that customers recognize the value of our products, including improved performance over existing soft tissue reconstruction materials,” said Antony Koblish, co-founder, President and Chief Executive Officer of TELA Bio. “In November we successfully...

Continue reading

BeyondSpring Provides Third-Quarter 2019 Operational and Financial Results Update

Preparing to Submit NDA in China for Chemotherapy-Induced Neutropenia (“CIN”) in Q1 2020Plinabulin’s Anti-Cancer and CIN Prevention Mechanism Published in Peer Reviewed JournalsNEW YORK, Dec. 18, 2019 (GLOBE NEWSWIRE) —  BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today provided an update on the Company’s operations and announced its financial results for the three months ended September 30, 2019.“We are pleased with the progress we are seeing in our clinical programs surrounding our lead compound, Plinabulin, for the treatment of non-small cell lung cancer (NSCLC) and CIN,” said Dr. Lan Huang, BeyondSpring’s Co-Founder, Chairman and Chief...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.